INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 198 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $59,000 | -40.4% | 938 | +17.5% | 0.01% | -25.0% |
| Q4 2019 | $99,000 | +167.6% | 798 | +42.5% | 0.01% | +200.0% |
| Q3 2019 | $37,000 | -78.1% | 560 | -45.5% | 0.00% | -82.6% |
| Q3 2016 | $169,000 | -40.7% | 1,027 | -48.6% | 0.02% | -34.3% |
| Q2 2016 | $285,000 | +40.4% | 2,000 | +26.6% | 0.04% | +40.0% |
| Q1 2016 | $203,000 | -17.1% | 1,580 | -3.7% | 0.02% | 0.0% |
| Q4 2015 | $245,000 | -15.2% | 1,640 | -5.7% | 0.02% | -13.8% |
| Q3 2015 | $289,000 | -22.3% | 1,740 | +13.0% | 0.03% | -9.4% |
| Q2 2015 | $372,000 | -4.1% | 1,540 | -6.1% | 0.03% | +3.2% |
| Q3 2014 | $388,000 | – | 1,640 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |